GC Genome

지씨지놈 · 340450

Industrials Commercial Services · KOSDAQ

Small-cap

Market cap US$95.6M (₩132B)

Overview

GC Genome provides genomic testing and analysis services, laboratory work that reads a person's DNA to support medical diagnosis, health screening, or research.

Its services are used by healthcare providers, research institutions, and individuals seeking genetic insights. The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$22.9M
Operating profit · FY2025
US$895.4K
Net income · FY2025
US$2.9M

Revenue

  • FY2025US$22.9M

Operating profit

  • FY2025US$895.4K

Net income

  • FY2025US$2.9M

Key ratios (FY2025)

ROE
5.2%
Debt/Eq
8.1%
Op. margin
3.9%
Net margin
12.8%
Rev. YoY
N/A (see filing)

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.